Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Kits and products designed to test an individual for the SARS-CoV-2 virus that is known to cause COVID-19; includes rapid tests, reagents, controls, stock, culture fluid, and other products.
SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus.
This product is intended for research, analytical testing during product development, or quality assurance testing. Viral culture fluids are sold as consumable testing materials, and are not for propagation or commercialization.
This COVID-19 over-the-counter rapid antigen test provides results in minutes with a unique all-in-one test device and nasal swab. InteliSwab™ COVID-19 Rapid Test is one of the easiest rapid tests with less than 1 minute of hands on time and only 3 key steps: Swab, Swirl and See.
SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control is formulated with purified, intact viral particles (Positive control) and human A549 cells (Negative control).
SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus.
NATtrol™ SARS-CoV-2 (recombinant) Stock is formulated with purified, intact bacterial cells that have been chemically modified to render them non-infectious and refrigerator stable.
NATtrol™ Coronavirus SARS Stock (Qualitative) is formulated with purified, intact virus particles that have been chemically modified to render them non-infectious and refrigerator stable.
The SCoV-2 Ag Detect™ Rapid Test is a lateral flow chromatographic immunoassay intended for the qualitative detection of the SARS-CoV-2 nucleocapsid protein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider.
A rapid, lateral flow immunoassay intended for the in-vitro simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV- 2, Influenza A, and Influenza B directly from nasopharyngeal swab specimens. The Status COVID-19/Flu Test is only for use under FDA EUA.